Evidence of an EGF/TGF-α—independent pathway for estrogen-regulated cell proliferation
✍ Scribed by B. S. Leung; L. Stout; L. Zhou; H. J. Ji; Q. Q. Zhang; H. T. Leung
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 745 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
To elucidate the relationship between epidermal growth factor (EGF)/transforming growth factor (TGF-a) and estradiol-17p (E) in cell proliferation, we examined their effects on the breast cancer cell line, CAMA-1. While E was able to consistently induce cell proliferation under a variety of experimental conditions, EGF/TGF-a was without effect. Despite the presence of the receptor (EGFR) gene, mature EGFR protein and mRNA were not detected by radioreceptor assay, 35S Met-labelling, and the lntron Differential RNNPCR method under conditions in which cells remain responsive to E. Furthermore, TGF-a is not an autocrine factor in CAMA-1 cells. We demonstrated unequivocally that EGFDGF-a interaction with EGFR is not an obligatory event in mediating estrogen-stimulated cell proliferation.
📜 SIMILAR VOLUMES
## We previously reported that chemokine Growth Regu lated Oncogene 1 (Gro 1) is over-expressed in murine squamous cell carcinoma (SCC) with metastatic tumor progression. The enhanced expression of Gro-1 gene by SCC is regulated by activation of nuclear factor-B (NF-B), leading to accelerated tumor
In many cancer cell lines, including breast, prostate, lung, brain, head and neck, retina, and the gastrointestinal tract, opioids decrease cell proliferation in a dose-dependent and reversible manner. Opioid and/or other neuropeptide receptors mediate this decrease. We report that only the steroid-
## Abstract A series of ferrocene derivatives based upon the structure of the antiestrogenic drug tamoxifen or of its active metabolite hydroxytamoxifen has been prepared and named by analogy ferrocifens and hydroxyferrocifens. This series includes 1‐[4‐(O(CH~2~)~__n__~NMe~2~)phenyl]‐1‐phenyl‐2‐fer
The human leukemic cell line AML-193 was tested for its proliferative response to endogenously produced autocrine factors and to a variety of cytokines and colony-stimulating factors. Cells grown in the absence of GM-CSF incorporated tritiated thymidine, and this was partially reversed by adding neu